Group Mafra’s Acquisition Of Biogenetix


Pinheiro Guimarães advised Group Mafra Hospitalar, while Boccuzzi Advogados advised the selling shareholders in the transaction.

Group Mafra, acting through CM Hospitalar, has agreed to acquire Biogenetix, a company specialized in the sale and distribution of medical diagnosis equipment in Brazil, for an undisclosed amount.

The transaction is part of an strategic plan of Group Mafra to enhance its ability to offer complete and integrated solutions to its clients and a larger portfolio of medical products and equipment.

Pinheiro Guimarães advised Group Mafra Hospitalar, with a team led by partner Rodrigo Marcilio (Picture) and associates Carolina Cardoso Ramalho, Isis Faria, Caio Ferreira and Alexandre Vendramini.

Boccuzzi Advogados advised the selling shareholders, with a team led by partner Marco Orlandi.

Involved fees earner: Marco Ferreira Orlandi – Boccuzzi Advogados; Carolina Cardoso Ramalho – Pinheiro Guimarães; Caio Ferreira – Pinheiro Guimarães; Isis Garcia de Faria – Pinheiro Guimarães; Rodrigo Marcilio – Pinheiro Guimarães; Alexandre Vendramini – Pinheiro Guimarães;

Law Firms: Boccuzzi Advogados; Pinheiro Guimarães;

Clients: Biogenetix; Mafra Hospitalar;